山西仟源医药集团股份有限公司

Chinese pharmaceutical group with its head office in Shanghai, founded on 23 March 2005 as Shanxi Qianyuan Pharmaceutical, converted to a joint stock company in June 2010, listed on the Shenzhen ChiNext board on 19 August 2011 and renamed Shanxi C&Y Pharmaceutical Group in September 2014 under code 300254. Employs more than 1,600 people and integrates research, manufacturing and marketing of medicines and health foods along with medical laboratory testing, gene storage and other healthcare services across all 34 Chinese provincial administrative regions, extending into international markets and precision medicine. Its products cover anti-infectives, antihistamines, urological drugs, smoking cessation, paediatric medicines, respiratory drugs, antidepressants, kidney disease treatments, novel oral anticoagulants, antihypertensives, health foods and DNA storage services.